Balyasny Asset Management’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,963	Closed	-$224K	–	2528
2024 Q1	$224K	Buy	2,963 +895	+43%	+$67.7K	﹤0.01%	1749
2023 Q4	$368K	Buy	+2,068	New	+$368K	﹤0.01%	1543
2022 Q3	–	Sell	-5	Closed	-$13K	–	2829
2022 Q2	$13K	Buy	+5	New	+$13K	﹤0.01%	2097